Pheochromocytoma differential diagnosis: Difference between revisions
Jump to navigation
Jump to search
| Line 18: | Line 18: | ||
*[[Stress]] | *[[Stress]] | ||
*[[Exercise]] | *[[Exercise]] | ||
*[[Medication]]s such as [[stimulant]]s, [[methyldopa]], [[dopamine | *[[Medication]]s such as [[stimulant]]s, [[methyldopa]], and [[dopamine agonist]]s | ||
==References== | ==References== | ||
Revision as of 18:13, 11 September 2015
|
Pheochromocytoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Pheochromocytoma differential diagnosis On the Web |
|
American Roentgen Ray Society Images of Pheochromocytoma differential diagnosis |
|
Risk calculators and risk factors for Pheochromocytoma differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Ahmad Al Maradni, M.D. [2]
Overview
Pheochromocytoma must be differentiated from anxiety, carcinoid, and hypoglycemia.
Differentiating Pheochromocytoma from other Diseases
The differential diagnosis of pheochromocytoma includes:
- Anxiety disorders
- Carcinoid tumor
- Paragangliomas
- Essential hypertension
- Hyperthyroidism
- Insulinoma
- Paroxysmal supraventricular tachycardia
- Renovascular hypertension
- Hypoglycemia
- Stress
- Exercise
- Medications such as stimulants, methyldopa, and dopamine agonists